CHICAGO — Patients with diabetic macular edema treated with suprachoroidal triamcinolone in combination with aflibercept achieved similar vision in fewer treatment visits compared with patients treated with aflibercept monotherapy, according to a speaker here.
“A combination of aflibercept and suprachoroidal triamcinolone vs. aflibercept monotherapy at week 24 showed similar vision changes, improved OCT central subfield thickness changes in the combination group and similar retinopathy score changes,” Michael S. Ip, MD, said at the American Society of Retina Specialists
Uncategorized